A Case of Pyoderma Gangrenosum in a Patient with Rheumatoid Arthritis Treated with Abatacept

被引：5

作者：

Akahoshi-Ikeda, Maki ^{[1
]}

Yoshizawa, Seiji ^{[2
]}

Motoshita, Junichi ^{[3
]}

Fume, Masutaka ^{[4
]}

Takeuchi, Satoshi ^{[1
,4
]}

机构：

[1] Hamanomachi Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Dermatol, Chuo Ku, Nagahama 3-3-1, Fukuoka 8108539, Japan

[2] Hamanomachi Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Rheumatol, Chuo Ku, Nagahama 3-3-1, Fukuoka 8108539, Japan

[3] Hamanomachi Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Pathol, Chuo Ku, Nagahama 3-3-1, Fukuoka 8108539, Japan

[4] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan

来源：

ACTA DERMATO-VENEREOLOGICA | 2016年 / 96卷 / 06期

关键词：

THERAPY; INFLAMMATION; INFLIXIMAB;

D O I：

10.2340/00015555-2380

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Pyoderma gangrenosum (PG) is a neutrophilic dermatosis induced by trauma or infection, which frequently appears on the lower legs. Various autoimmune diseases and systemic tumour necrosis factor (TNF)-α-blocking treatment cause PG, suggesting that T-cell-mediated reactions are involved in the aetiology. We report here for the first time a case of PG occurring during treatment with abatacept, a T-cell co-stimulation blocker. In addition, we discuss a possible underlying disease mechanism. © 2016 The Authors.

引用

页码：822 / 823

页数：2

共 50 条

[31] Mesangial immunoglobulin (Ig)A glomerulonephritis in a patient with rheumatoid arthritis treated with abatacept
Michel, Murielle
Henri, Patrick
Vincent, Fabien B.
Leon, Nathalie
Marcelli, Christian
[J]. JOINT BONE SPINE, 2013, 80 (06) : 660 - 663
[32] Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study
Kridin, Khalaf
Damiani, Giovanni
Cohen, Arnon D.
[J]. CLINICAL RHEUMATOLOGY, 2021, 40 (02) : 521 - 528
[33] Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study
Khalaf Kridin
Giovanni Damiani
Arnon D. Cohen
[J]. Clinical Rheumatology, 2021, 40 : 521 - 528
[34] Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: "JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum"
dos Santos, Mayra Rabelo
Ianhez, Mayra
Ribeiro, Bruno Nazeozeno
de Queiroz, Boaventura Braz
Miot, Helio Amante
[J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (11) : E595 - E598
[35] Pyoderma gangrenosum and neutrophilic aortitis preceding the development of rheumatoid arthritis
Linck, V.
Sanchez, B.
Baubion, E.
Molinie, V.
Deligny, C.
Quist, D.
Derancourt, C.
[J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2015, 142 (6-7): : 425 - 429
[36] Pyoderma gangrenosum of the breast associated with rheumatoid arthritis: A challenging diagnosis
Ouni, Nour El Imene
Korbi, Mouna
Ben Salah, Nesrine
Kammoun, Mariem
Ahlem, Bellalah
Belhadjali, Hichem
Youssef, Monia
Zakhama, Abdelfattah
Touzi, Mongi
Zili, Jameleddine
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (03) : 373 - 374
[37] Pyoderma gangrenosum treated with secukinumab: A case report
McPhie, Meghan L.
Kirchhof, Mark G.
[J]. SAGE OPEN MEDICAL CASE REPORTS, 2020, 8
[38] Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis
Vandevyvere, K.
Luyten, F. P.
Verschueren, P.
Lories, R.
Segaert, S.
Westhovens, R.
[J]. CLINICAL RHEUMATOLOGY, 2007, 26 (12) : 2205 - 2206
[39] A drug of three diseases. Use of cyclosporine in a patient with pyoderma gangrenosum, rheumatoid arthritis and myelodysplasia
Cestari, R.
Devoti, F.
Nazzari, G.
[J]. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2010, 145 (03): : 3 - 4
[40] Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis
K. Vandevyvere
F. P. Luyten
P. Verschueren
R. Lories
S. Segaert
R. Westhovens
[J]. Clinical Rheumatology, 2007, 26 : 2205 - 2206

← 1 2 3 4 5 →